You Might Also Like
Also By This Author
- Gladman DD, Rigby W, Azevedo VF, et al. Efficacy and safety of tofacitinib, an oral janus kinase inhibitor, in patients with active psoriatic arthritis and an inadequate response to tumor necrosis factor inhibitors: OPAL beyond, a randomized, double blind, placebo-controlled Phase 3 trial [abstract]. Arthritis Rheumatol. 2016;68 (suppl 10).